Advertisement

Topics

Strategia Holdings, LLC Company Profile

15:55 EST 21st February 2019 | BioPortfolio

Strategia Holdings, LLC, is based in the U.S. and oversees three biotech companies; Spirita Oncology, LLC, Mirata BioPharma, LLC, and Strategia Pharmaceuticals, LLC. Spirita focuses on oncology drug development in the US with E6201, a MEK1 inhibitor, as their flagship candidate focused on melanoma brain metastases. Mirata is a pre-clinical stage immuno-oncology company based on a Targeted Granzyme B Immunotherapy (TGI) platform. Strategia Pharmaceuticals was established in 2012 consisting of oncology pharma and biotech drug development veterans, and is a strategic consulting company to assist pharma and biotech clients develop their oncology portfolios with greater expertise, more efficiently, more rapidly, translating into lower overall cost to market.


News Articles [463 Associated News Articles listed on BioPortfolio]

Strategia of Boston Forms Drug Development Partnership with Shanghai's JS InnoPharm

Strategia Holdings of Boston partnered with JS InnoPharm (Shanghai) to develop drugs for global markets. Strategia forms partnerships on its drug projects, using small groups of experts, rather than d...

Strategia Holdings Announces Strategic Partnership Alliance with JS InnoPharm (Shanghai) for Global Drug Development

Strategia Holdings, LLC. announced a strategic partnership alliance with JS InnoPharm (Shanghai), Ltd. to facilitate global drug development. Through this partnership, both c...

Strategia Holdings Announces Strategic Partnership Alliance with JS InnoPharm (Shanghai) for ...

Read more...

Strategia, JS InnoPharm Partner for Development

The strategic partnership alliance aims to facilitate global drug development of multiple therapeutics

Sears Holdings Seeks Court Approval Of Stalking Horse Asset Purchase Agreement With Service. ...

HOFFMAN ESTATES, Ill., Nov. 3, 2018 /PRNewswire/ -- Sears Holdings Corporation ("Holdings" or the "Company") (OTC Pink: SHLDQ) today announced that it has sought court Read more...

Hemp Leader Charlotte's Web Holdings Inc May Be a Potential Marijuana Giant in 2019

Charlotte's Web Holdings Stock Forecast Charlotte's Web Holdings Inc (OTCMKTS:CWBHF, CNSX:CWEB) may just be the best hemp stock you've never heard of. Thanks to industrialized hemp being legalized ...

Fortress Biotech Announces Agreement to Sell Its Majority Stake in National Holdings Corporation to NHC Holdings, LLC, a wholly-owned subsidiary of B. Riley Financial

NEW YORK, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmace...

This Day That Year: Motus GI Holdings

Shares of Motus GI Holdings Inc. (MOTS) are down nearly 60% from their 52-week high of $10.66 recorded on July 9, 2018.

PubMed Articles [6 Associated PubMed Articles listed on BioPortfolio]

Destroyed by Slavery? Slavery and African American Family Formation Following Emancipation.

This study introduces a new sample that links people and families across 1860, 1880, and 1900 census data to explore the intergenerational impact of slavery on black families in the United States. Sla...

Six-Year Prospective Outcomes of Primary Breast Augmentation With Nano Surface Implants.

Motiva Implants (Establishment Labs Holdings Inc.) are a novel family of silicone breast implants using cutting-edge technologies engineered to optimize aesthetic and safety outcomes.

Early clinical results with the Tendyne transcatheter mitral valve replacement system.

Transcatheter mitral valve replacement is an emerging technology for the treatment of mitral valve regurgitation. Numerous devices are in development and in various stages of clinical investigation. T...

Four years of African swine fever in Poland. New insights into epidemiology and prognosis of future disease spread.

Four and a half years of African Swine Fever (ASF) in population of free-ranging wild boars and domestic pigs revealed a number of novel insights into the disease epidemiology. Until No- vember 20th, ...

A survey of digitized data from U.S. fish collections in the iDigBio data aggregator.

Recent changes in institutional cyberinfrastructure and collections data storage methods have dramatically improved accessibility of specimen-based data through the use of digital databases and data a...

Clinical Trials [4 Associated Clinical Trials listed on BioPortfolio]

Expanded Access With Trappsol(R) Cyclo (TM) for an Individual Patient With Late Onset Alzheimer's Disease

To afford urgent access to a potential-disease modifying treatment, Dr. Diana Kerwin, in partnership with CTD Holdings, the manufacturer of Trappsol (R) Cyclo(TM), will administer the prod...

Study of Pharmacokinetics and Preliminary Efficacy in Patients With Niemann-Pick C1

This research study is being conducted to find out whether Trappsol® Cyclo™, an experimental treatment for people with Niemann-Pick disease Type C1 (NPC-1) is safe at 3 different dose l...

Study of the Pharmacokinetics of Trappsol and Effects on Potential Biomarkers of Niemann-Pick C1 (NPC1)

This research study is being conducted to find out whether Trappsol® Cyclo™, an experimental treatment for people with Niemann Pick disease Type C (NPC-1) is safe at 2 different dose le...

Frequent Fallers' Experiences of an Adapted Walking Frame, Designed to Reduce the Walking Aid's Associated Falls Risk

For some patients with mobility issues, a walking frame (commonly known as a zimmer frame - trademark of Zimmer Holdings), is provided to keep them on their feet and help them remain more ...

Companies [474 Associated Companies listed on BioPortfolio]

Strategia Holdings, LLC

Strategia Holdings, LLC, is based in the U.S. and oversees three biotech companies; Spirita Oncology, LLC, Mirata BioPharma, LLC, and Strategia Pharmaceuticals, LLC. Spirita focus...

Strategia Therapeutics Inc.

Strategia is an integrated pharmaceutical company with the goal of delivering new therapeutics faster, more efficiently, and at lower overall cost to the drug development process ...

Strategia Therapeutics, Inc.

【Startegia Therapeutics, Inc. Profile】

Integra Holdings

Founded by Yissum, Integra Holdings is a unique venture fund, focusing on an exclusive selection of biotech companies with proprietary solutions and a competitive advantage in the...

Sabre Holdings

Sabre Holdings connects people with the world's greatest travel possibilities by retailing travel products and providing distribution and technology solutions for the travel indus...

More Information about "Strategia Holdings, LLC" on BioPortfolio

We have published hundreds of Strategia Holdings, LLC news stories on BioPortfolio along with dozens of Strategia Holdings, LLC Clinical Trials and PubMed Articles about Strategia Holdings, LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Strategia Holdings, LLC Companies in our database. You can also find out about relevant Strategia Holdings, LLC Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record